ACY-775

CAS No. 1375466-18-4

ACY-775 ( ACY 775;ACY775 )

Catalog No. M11553 CAS No. 1375466-18-4

ACY-775 (ACY775) is a potent and specific HDAC6 inhibitor (IC50=7.5 nM) with improved brain bioavailability.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 39 Get Quote
5MG 65 Get Quote
10MG 110 Get Quote
25MG 230 Get Quote
50MG 372 Get Quote
100MG 556 Get Quote
500MG 1197 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ACY-775
  • Note
    Research use only, not for human use.
  • Brief Description
    ACY-775 (ACY775) is a potent and specific HDAC6 inhibitor (IC50=7.5 nM) with improved brain bioavailability.
  • Description
    ACY-775 (ACY775) is a potent and specific HDAC6 inhibitor (IC50=7.5 nM) with improved brain bioavailability; 60-1500 fold selectivity over class I HDACs; no activity against all other class II HDAC isoforms (IC50>1uM); induce dramatic increases in α-tubulin acetylation in brain and stimulate mouse exploratory behaviors; increases the innervation of the neuromuscular junctions in the gastrocnemius muscle and improves the motor and sensory nerve conduction in the mutant HSPB1-induced CMT2 mouse model.
  • Synonyms
    ACY 775;ACY775
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1375466-18-4
  • Formula Weight
    330.36
  • Molecular Formula
    C17H19FN4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL 302.70 mM
  • SMILES
    O=C(C1=CN=C(NC2(C3=CC=CC(F)=C3)CCCCC2)N=C1)NO
  • Chemical Name
    2-((1-(3-fluorophenyl)cyclohexyl)amino)-N-hydroxypyrimidine-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jochems J, et al. Neuropsychopharmacology. 2014 Jan;39(2):389-400.
2. Benoy V, et al. Neurotherapeutics. 2017 Apr;14(2):417-428.
molnova catalog
related products
  • AES-135

    AES-135 (AES135) is a novel HDAC inhibitor that biochemically inhibits HDACs 3, 6, 8 and 11 with IC50 values of 190-1100 nM.

  • OBP-801

    OBP-801 (YM 753;Spiruchostatin A) is a novel cyclic-peptide-based HDAC inhibitor with IC50 of 2 nM.

  • Givinostat

    Givinostat hydrochloride monohydrate is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively.